ORIGINAL
Uso del antígeno prostático específico en atención primaria (PSA)
Use of prostatic specific antigen in primary care (PSA)
J. Panach-Navarrete
, A. Gironés-Montagud, E. Sánchez-Cano, C. Doménech-Pérez, J.M. Martínez-Jabaloyas
Autor para correspondencia
Servicio de Urología, Hospital Clínico Universitario de Valencia, Valencia, España
Leído
14967
Vecesse ha leído el artículo
2121
Total PDF
12846
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 38 | 4 | 42 |
| 2025 11 | 112 | 26 | 138 |
| 2025 10 | 122 | 34 | 156 |
| 2025 9 | 104 | 19 | 123 |
| 2025 8 | 98 | 20 | 118 |
| 2025 7 | 101 | 13 | 114 |
| 2025 6 | 89 | 7 | 96 |
| 2025 5 | 105 | 10 | 115 |
| 2025 4 | 108 | 6 | 114 |
| 2025 3 | 154 | 16 | 170 |
| 2025 2 | 178 | 21 | 199 |
| 2025 1 | 128 | 6 | 134 |
| 2024 12 | 103 | 6 | 109 |
| 2024 11 | 152 | 10 | 162 |
| 2024 10 | 145 | 14 | 159 |
| 2024 9 | 146 | 15 | 161 |
| 2024 8 | 117 | 17 | 134 |
| 2024 7 | 103 | 7 | 110 |
| 2024 6 | 131 | 11 | 142 |
| 2024 5 | 132 | 11 | 143 |
| 2024 4 | 150 | 18 | 168 |
| 2024 3 | 114 | 12 | 126 |
| 2024 2 | 143 | 11 | 154 |
| 2024 1 | 133 | 13 | 146 |
| 2023 12 | 132 | 11 | 143 |
| 2023 11 | 163 | 11 | 174 |
| 2023 10 | 194 | 20 | 214 |
| 2023 9 | 100 | 4 | 104 |
| 2023 8 | 111 | 8 | 119 |
| 2023 7 | 168 | 9 | 177 |
| 2023 6 | 208 | 20 | 228 |
| 2023 5 | 280 | 25 | 305 |
| 2023 4 | 172 | 23 | 195 |
| 2023 3 | 209 | 20 | 229 |
| 2023 2 | 145 | 11 | 156 |
| 2022 1 | 102 | 23 | 125 |
| 2022 12 | 109 | 10 | 119 |
| 2022 11 | 184 | 27 | 211 |
| 2022 10 | 150 | 28 | 178 |
| 2022 9 | 144 | 32 | 176 |
| 2022 8 | 139 | 15 | 154 |
| 2022 7 | 92 | 15 | 107 |
| 2022 6 | 107 | 13 | 120 |
| 2022 5 | 140 | 21 | 161 |
| 2022 4 | 109 | 23 | 132 |
| 2022 3 | 117 | 18 | 135 |
| 2022 2 | 73 | 14 | 87 |
| 2021 1 | 111 | 25 | 136 |
| 2021 12 | 102 | 26 | 128 |
| 2021 11 | 136 | 34 | 170 |
| 2021 10 | 89 | 19 | 108 |
| 2021 9 | 80 | 13 | 93 |
| 2021 8 | 86 | 18 | 104 |
| 2021 7 | 52 | 21 | 73 |
| 2021 6 | 80 | 17 | 97 |
| 2021 5 | 98 | 14 | 112 |
| 2021 4 | 262 | 18 | 280 |
| 2021 3 | 99 | 31 | 130 |
| 2021 2 | 79 | 20 | 99 |
| 2020 1 | 81 | 16 | 97 |
| 2020 12 | 98 | 14 | 112 |
| 2020 11 | 104 | 9 | 113 |
| 2020 10 | 88 | 6 | 94 |
| 2020 9 | 85 | 15 | 100 |
| 2020 8 | 110 | 22 | 132 |
| 2020 7 | 90 | 5 | 95 |
| 2020 6 | 101 | 19 | 120 |
| 2020 5 | 91 | 17 | 108 |
| 2020 4 | 104 | 16 | 120 |
| 2020 3 | 324 | 27 | 351 |
| 2020 2 | 148 | 23 | 171 |
| 2020 1 | 121 | 20 | 141 |
| 2019 12 | 134 | 16 | 150 |
| 2019 11 | 177 | 26 | 203 |
| 2019 10 | 247 | 21 | 268 |
| 2019 9 | 237 | 23 | 260 |
| 2019 8 | 153 | 16 | 169 |
| 2019 7 | 186 | 21 | 207 |
| 2019 6 | 252 | 43 | 295 |
| 2019 5 | 367 | 75 | 442 |
| 2019 4 | 353 | 40 | 393 |
| 2019 3 | 120 | 12 | 132 |
| 2019 2 | 129 | 23 | 152 |
| 2019 1 | 95 | 24 | 119 |
| 2018 12 | 69 | 20 | 89 |
| 2018 11 | 167 | 38 | 205 |
| 2018 10 | 193 | 23 | 216 |
| 2018 9 | 94 | 54 | 148 |
| 2018 8 | 36 | 104 | 140 |
| 2018 7 | 67 | 65 | 132 |
| 2018 6 | 46 | 33 | 79 |
| 2018 5 | 60 | 46 | 106 |
| 2018 4 | 88 | 23 | 111 |
| 2018 3 | 54 | 16 | 70 |
| 2018 2 | 46 | 7 | 53 |
| 2018 1 | 47 | 9 | 56 |
| 2017 12 | 47 | 4 | 51 |
| 2017 11 | 65 | 11 | 76 |
| 2017 10 | 73 | 6 | 79 |
| 2017 9 | 8 | 3 | 11 |
| 2017 7 | 3 | 0 | 3 |
| 2017 6 | 10 | 0 | 10 |
| 2017 5 | 128 | 17 | 145 |
| 2017 4 | 5 | 6 | 11 |
| 2017 3 | 6 | 24 | 30 |
| 2017 2 | 1 | 13 | 14 |
| 2016 1 | 0 | 7 | 7 |
| 2016 12 | 1 | 15 | 16 |
| 2016 11 | 1 | 10 | 11 |
| 2016 10 | 2 | 13 | 15 |
| 2016 9 | 3 | 11 | 14 |
| 2016 8 | 3 | 7 | 10 |
| 2016 7 | 0 | 3 | 3 |
Mostrar todo
